Finance

Lists
KZIA:NASDAQ
Kazia Therapeutics Ltd
9,21 $
-0,54%
(-0,050) 1D
7 հոկ, 10:19:12 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KZIA...
Open
9,20 $
High
9,28 $
Low
9,14 $
Mkt. cap
139,06 մլն
Avg. vol.
346,81 հզր
Volume
27,39 հզր
52-wk high
17,40 $
52-wk low
4,86 $
EPS
-6,35 $
Beta
2,68
Shares outstanding
15,25 մլն
No. of employees
6
Open
9,20 $
High
9,28 $
Low
9,14 $
Mkt. cap
139,06 մլն
Avg. vol.
346,81 հզր
Volume
27,39 հզր
52-wk high
17,40 $
52-wk low
4,86 $
EPS
-6,35 $
Beta
2,68
Shares outstanding
15,25 մլն
No. of employees
6
News stories
From web sources and news partners
About Kazia Therapeutics Ltd
CEO-
Employees6
Founded1994
Headquarters-
Sector-
Websitekaziatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to KZIA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KZIA in the last 3 months.
Highest
Current 9,21 $
40,00 $ (+334,31%)
Average
29,25 $ (+217,59%)
Lowest
18,00 $ (+95,44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
18,00 $
+95,4%
10/01/2026
Kambiz Yazdi
BTIG
Buy
Maintained
40,00 $
+334,3%
09/22/2026
John Newman
Canaccord Genuity
Buy
Reiterated
29,00 $
+214,9%
09/01/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
29,00 $
+214,9%
08/13/2026
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 $
+225,7%
07/15/2026
Chad Messer
Lake Street
Buy
Initiated
32,00 $
+247,4%
06/11/2026
Yale Jen
Laidlaw
Buy
Initiated
25,00 $
+171,4%
04/15/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
903,36 հզր
903,36 հզր
45,96 հզր
45,96 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 մլն
1,52 մլն
2,50 մլն
2,50 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,81 մլն
1,81 մլն
4,28 մլն
4,28 մլն
Operating expense
3,33 մլն
3,33 մլն
6,78 մլն
6,78 մլն
Total operating expenses
3,33 մլն
3,33 մլն
6,78 մլն
6,78 մլն
Operating income
-2,42 մլն
-2,42 մլն
-6,73 մլն
-6,73 մլն
Other non operating income
-239,18 հզր
-239,18 հզր
372,46 հզր
372,46 հզր
EBT including unusual items
-5,93 մլն
-5,93 մլն
-6,28 մլն
-6,28 մլն
EBT excluding unusual items
-2,64 մլն
-2,64 մլն
-6,28 մլն
-6,28 մլն
Income tax expense
-805,23 հզր
-805,23 հզր
-
-
Effective tax rate
13,58%
13,58%
-
-
Other operating expenses
-
-
-
-
Net income
-5,12 մլն
-5,12 մլն
-6,28 մլն
-6,28 մլն
Net profit margin
-567,23%
-567,23%
-13 655,59%
-13 655,59%
Earnings per share
-
-
-
-
Interest and investment income
21,67 հզր
21,67 հզր
80,46 հզր
80,46 հզր
Interest expense
-
-
-
-
Net interest expenses
21,67 հզր
21,67 հզր
80,46 հզր
80,46 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,11 մլն
-2,19 մլն
-6,50 մլն
-6,50 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps